Recall Register

Food, drugs, devices › Philips Ultrasound, Inc.

Device recall: Philips EPIQ Diagnostic Ultrasound System Models: EPIQ 7G(model # 795200), EPIQ 7C (Model # 795201), EPIQ 7W (Model # 79

FDA enforcement event 93218 · Class II · initiated 9 Oct 2023 · status Completed

DeviceVoluntary: Firm initiated2 product recordsBothell, WA

Philips Ultrasound, Inc. (Bothell, WA) initiated this device recall on 9 Oct 2023; FDA lists 2 product records under event 93218, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 917 device enforcement events initiated in 2023 carry the same class.

Status: Completed. Initiation: voluntary: firm initiated. Philips Ultrasound, Inc. has 22 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips Ultrasound, Inc., Bothell, WA.

Reason for recall

"Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image."

Distribution

"US: AZ, CA, CT, FL, GA, ID, IL, KY, MD, MT, NE, NV, OH, TN, TX, UT, VA OUS: Canada"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0283-2024Philips EPIQ Diagnostic Ultrasound System Models: EPIQ 7G(model # 795200), EPIQ 7C (Model # 795201), EPIQ 7W (Model # 795202), EPIQ 5G (model # 795204), EPIQ 5W (model # 795206), EPIQ CVx (Model # 795231), EPIQ Elite (model # 795234)83 systemsClass IICompleted15 Nov 2023
Z-0284-2024Philips Affiniti 70, Diagnostic Ultrasound System Model # 7952107 systemsClass IICompleted15 Nov 2023

Context

88%of 2023 device events are Class II917 events that year
2product records in this eventfirm median: 2
22events on this register for the firm

Other enforcement events for Philips Ultrasound, Inc.

InitiatedProduct (first record)TypeClassRecords
5 Sep 2025Philips 3D6-2 Ultrasound TransducerDeviceClass III11
3 Jul 20253D6-2 Transducer ProbeDeviceClass III69
28 May 2025Philips 3D9-3v Transducer.DeviceClass II21
23 Mar 20245000 Compact Series Ultrasound Systems, Product/REF: 5500 CV/795141, 5500 P/795143, 5500 W/795144, 5500 G/795145, and PrDeviceClass II1
30 Jun 20233D9-3v Transducer, accessory to Philips Ultrasound Systems: EPIQ Elite; Affiniti 30, 50, and 70; ClearVue 850; HD15; iU2DeviceClass II1
21 Sep 2021EPIQ CVxi Diagnostic Ultrasound Systems, Product Code: 795232DeviceClass II1
19 Aug 2021Philips Ultrasound, Inc. Sparq, Diagnostic Ultrasound System, REF 795090, 100-240V -, 50/60 Hz, 500 VA, CE2797, Rx Only,DeviceClass II2
6 Aug 2021EPIQ Diagnostic Ultrasound Systems: Software Versions 5.0, 5.0.1 and 5.0.2 Models: EPIQ 5 - 795120 EPIQ 5C - 795205 EPIQDeviceClass II2
22 Jul 2021EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EPIQ CVx, EPIQ CVxiDeviceClass II1
24 Dec 2020Philips EPIQ Diagnostic Ultrasound System, Models EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EPIQDeviceClass II1

All 22 events for Philips Ultrasound, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US: AZ, CA, CT, FL, GA, ID, IL, KY, MD, MT, NE, NV, OH, TN, TX, UT, VA OUS: Canada"

Is the recall still ongoing?

FDA lists the status as Completed. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.